IP Library Granted Patent US 9,555,057
Granted Patent B2
US 9,555,057 · App. 14/869,738 · Granted Jan 31, 2017

Compositions and methods for reducing cutaneous microbiome malodor

Inventors: Israel Kleinberg (Smithtown, NY); Zegong Zhang (Stony Brook, NY)
Assignee: The Research Foundation for The State University of New York
A61K33/30A61K8/27A61K8/44A61K9/0014A61K31/198A61Q15/00A61K2800/592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,057
App. No.
14/869,738
Granted
Jan 31, 2017
Kind
B2
Abstract

A deodorant composition comprising arginine, bicarbonate, zinc and carbonate, preferably arginine bicarbonate and zinc carbonate (ABZC), and one or more physiologically acceptable excipients, administered for the modification of cutaneous microfloras—generally to reduce axillary odor, promote the growth of Staphylococcus epidermidis bacteria, inhibit the growth of Corynebacterium striatum bacteria, or any or all of the preceding.

Claims (25)

1. A body odor deodorant composition, comprising:

a. arginine, or a salt thereof;

b. a zinc salt;

c. a buffer sufficient to maintain the pH of said composition at 6.0 or greater upon topical application;

d. a physiologically-acceptable carrier suitable for topical cutaneous application, said composition provided as a topical formulation selected from the group consisting of soap, powder, roll-on, lotion, cream, stick, sachet, film, patch and ointment; and

e. phenylalanine.

2. The composition of claim 1 , said composition being capable of inhibiting the growth or metabolism of malodor-generating microbiota present in the cutaneous regions of a subpart of the human body.

3. The composition of claim 2 , wherein said cutaneous regions comprise the axilla and foot-webs.

4. The composition of claim 2 , said composition being capable of inhibiting the generation of hydrogen sulfide by said microbiota.

5. The composition of claim 2 , said composition being capable of inhibiting the generation of isovaleric acid by said microbiota.

6. The composition of claim 2 , said composition being capable of inhibiting the generation of at least one of acetic acid and propionic acid by said microbiota.

7. The composition of claim 2 , said composition being capable of inhibiting the generation of at least one of hydrogen sulfide, acetic acid, propionic acid and isovaleric acid by said microbiota.

8. The composition of claim 1 , said composition being capable of inhibiting the growth or metabolism of Corynebacterium striatum.

9. The composition of claim 1 , wherein said zinc salt is selected from the group consisting of zinc carbonate, zinc bicarbonate, zinc glycinate, zinc acetate, zinc lactate and zinc arginate.

10. The composition of claim 9 , wherein said zinc carbonate is present at a concentration of 10% (w/v) or less.

11. The composition of claim 9 , wherein said zinc carbonate is present at a concentration of 5% (w/v) or less.

12. The composition of claim 1 , wherein said arginine, or a salt thereof is selected from the group consisting of arginine, arginine carbonate and arginine bicarbonate.

13. The composition of claim 12 , wherein said arginine bicarbonate is present at a concentration of 10% (w/v) or less.

14. The composition of claim 12 , wherein said arginine bicarbonate is present at a concentration of 5% (w/v) or less.

15. The composition of claim 1 , wherein said zinc salt is zinc carbonate and said arginine salt is arginine bicarbonate.

16. The composition of claim 1 , wherein said composition upon topical application has a pH of at least 7.0.

17. The composition of claim 1 , wherein said composition upon topical application has a pH of at least 8.0.

18. The composition of claim 1 , wherein said composition upon topical application has a pH of at least 9.0.

19. A composition for altering the bacterial degradation products of perspiration odor, comprising zinc carbonate and arginine bicarbonate, and a physiologically-acceptable carrier suitable for topical application, wherein said composition upon topical application has a pH of 6.0 or greater, said composition provided as a topical formulation selected from the group consisting of soap, powder, roll-on, lotion, cream, stick, sachet, film, patch and ointment.

20. A method for treating malodor, comprising topically applying to a cutaneous region of a subject in need thereof, a composition including an arginine salt; a zinc salt; a physiologically-acceptable carrier suitable for topical body cutaneous application; and phenylalanine, wherein said composition upon topical application has a pH of 6.0 or greater, and said composition provided as a topical formulation selected from the group consisting of soap, powder, roll-on, lotion, cream, stick, sachet, film, patch and ointment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2015
From: KLEINBERG, ISRAEL; ZHANG, ZEGONG
To: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Reel/Frame 037055/0699 →
Continuity (3)
Provisional Application 62057040 · Sep 29, 2014
Provisional Application 62116082 · Feb 13, 2015
Related Publication 20160089315A1 · Mar 31, 2016